(HealthDay)—Patients with nonfunctional adrenal tumors (NFATs) have increased risk of diabetes compared to those without adrenal tumors, according to a study published online Aug. 2 in the Annals of Internal Medicine.
Aug 4, 2016
0
1
A University of North Carolina Lineberger Comprehensive Cancer Center-led study has identified genetic differences in tumors of African-Americans with the most common type of kidney cancer compared with whites.
Mar 30, 2016
0
0
Two widely used targeted therapy drugs approved by the FDA for the treatment of metastatic kidney cancer—sorafenib and sunitinib—are no more effective than a placebo in preventing return of the disease to increase life ...
Mar 10, 2016
0
0
The genetic basis of clear cell sarcoma of the kidney (CCSK), a high-risk childhood cancer known for metastasizing to bone and brain, has remained a mystery since the cancer was first described in the 1970s. A team of researchers ...
Nov 19, 2015
0
37
UT Southwestern Medical Center Kidney Cancer Program investigators have published what is believed to be the first reported successful use of stereotactic body radiation therapy for an often deadly complication of kidney ...
Apr 7, 2015
0
9
Kidney cancer is the eighth most commonly diagnosed cancer in the United States, with a five-year survival rate of 72.4 percent. At first glance, these survival rates compare advantageously to other seemingly deadlier cancers ...
Apr 6, 2015
0
23
If kidney cancer is diagnosed early—before it spreads—80 percent of patients survive. However, finding it early has been among the disease's greatest challenges.
Mar 19, 2015
0
183
Physicians at Henry Ford Hospital successfully suctioned a cancerous tumor from a major vein in a patient with metastatic kidney cancer, clearing the way for him to undergo a minimally-invasive kidney removal. This allowed ...
Feb 11, 2015
0
25
Using next generation gene sequencing techniques, cancer researchers at UT Southwestern Medical Center have identified more than 3,000 new mutations involved in certain kidney cancers, findings that help explain the diversity ...
Nov 17, 2014
0
0
Cincinnati Cancer Center (CCC) researchers have discovered that a membrane channel, Transient Receptor Potential Melastatin 3, or TRPM3, promotes growth of kidney cancer tumors, and targeting this channel therapeutically ...
Nov 10, 2014
0
0
